share_log

吉利德科学与美国政府就艾滋病药物达成10亿美元专利纠纷和解

Gilead Sciences reached a settlement with the USA government on a $1 billion patent dispute regarding AIDS drugs.

Gelonghui Finance ·  Jan 16 02:22

Gelonghui, January 16 | According to Reuters, a document submitted to the federal court in Delaware on Wednesday indicates that Gilead Sciences has reached a $1 billion settlement with the USA government regarding Gilead's HIV prevention drugs Truvada and Descovy. Previously, Gilead won a patent infringement lawsuit during a jury trial in 2023. Gilead's General Counsel Deborah Telman stated in a statement that the agreement allows "the company to continue focusing its resources on its mission to discover, develop, and provide innovative therapies to people with life-threatening diseases."

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
1
Comment Comment · Views 226

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.